Particle therapy

Hitachi Selected by the University of Tsukuba for its Second Proton Therapy System as a PFI Project

Monday, November 22, 2021 - 4:57am

The new proton therapy center will be equipped with Hitachi's compact design proton therapy system, including a set of one accelerator and two rotating gantry treatment rooms.

Key Points: 
  • The new proton therapy center will be equipped with Hitachi's compact design proton therapy system, including a set of one accelerator and two rotating gantry treatment rooms.
  • Image of New Proton Therapy Center; The new center is on the left of existing site
    The University of Tsukuba has been using Hitachi's proton therapy system since 2001.
  • Upon completion and opening of the new proton therapy center, the University of Tsukuba will shift its treatment from the existing center to the new center.
  • In 2001, the University of Tsukuba adopted Hitachi's proton therapy system and has provided proton therapy to approximately 6,000 cancer patients to date.

Best Medical International & TeamBest Global Will Exhibit at ASTRO 2022 Meeting in San Antonio, Texas on October 23–26

Tuesday, October 26, 2021 - 9:36pm

Best Medical International (BMI) & TeamBest Global Companies (TBG) are announcing they will be exhibiting at the 2022 ASTRO Meeting that will be held in San Antonio, Texas, October 2326.

Key Points: 
  • Best Medical International (BMI) & TeamBest Global Companies (TBG) are announcing they will be exhibiting at the 2022 ASTRO Meeting that will be held in San Antonio, Texas, October 2326.
  • In addition, BMI will introduce Proton Therapy Cyclotrons up to 150 MeV and 400 MeV ion Rapid Cycling Medical Synchrotrons (iRCMS) for Proton-to-Carbon Heavy Ion High Precision Radiation Therapy.
  • Best Medical International & TeamBest Global Companies' booth floorplan layout is approximately 5000 sq.
  • ft. and will be positioned near the entrance of the ASTRO 2022 exhibit space in San Antonio, Texas.

California Protons Treats 3,000th Patient with Proton Therapy

Tuesday, April 6, 2021 - 7:15pm

SAN DIEGO, April 6, 2021 /PRNewswire/ -- California Protons Cancer Therapy Center today announced the treatment of its 3,000th patient with proton therapy since the Center opened in 2014.

Key Points: 
  • SAN DIEGO, April 6, 2021 /PRNewswire/ -- California Protons Cancer Therapy Center today announced the treatment of its 3,000th patient with proton therapy since the Center opened in 2014.
  • "We are honored to have had 3,000 patients entrust us with their care," said Tom Wang, President of California Protons Cancer Therapy Center.
  • With decades of combined experience in proton therapy, these physicians have treated more than 15,000 patients with proton therapy.
  • California Protons Cancer Therapy Center is one of only two proton therapy centers in California and 37 nationwide.

Proton Therapy Partners Names Kevin Kriebel Vice President of Construction & Architectural Management

Tuesday, October 6, 2020 - 2:15pm

PHILADELPHIA, Oct. 6, 2020 /PRNewswire/ -- Proton Therapy Partners (PTP) has named Kevin Kriebel Vice President of Construction and Architectural Management.

Key Points: 
  • PHILADELPHIA, Oct. 6, 2020 /PRNewswire/ -- Proton Therapy Partners (PTP) has named Kevin Kriebel Vice President of Construction and Architectural Management.
  • In this role, Kevin will lead the planning and building of PTP's proton therapy centers nationwide.
  • Kevin is the most accomplished, experienced, and reputable expert in the design and construction of particle therapy centers.
  • Kevin is a graduate of the University of Florida, a member of Proton Therapy Cooperative Group and is OSHA 30 certified.

Carbon Therapy Segment in Particle Therapy Market to Grow at Exponential Growth Rate from 2018 to 2026: TMR

Thursday, September 17, 2020 - 4:30pm

- Brain and spinal cord tumors, pediatric cancer segments are contributing notably to growth in the particle therapy market over the forecast period

Key Points: 
  • - Brain and spinal cord tumors, pediatric cancer segments are contributing notably to growth in the particle therapy market over the forecast period
    ALBANY, N.Y., Sept. 17, 2020 /PRNewswire/ --From 2018 to 2026, the compound annual growth rate (CAGR) of global particle therapy market is anticipated to be 8%.
  • In the year 2017, it is quite pertinent to note, the market valuation stood at USD 364.8 million.
  • Request a sample of the study https://www.transparencymarketresearch.com/sample.php
    Competitive Landscape of Global Particle Therapy Market:
    The vendor landscape is marked by growth strategies that are shaping the future dynamics of the market.
  • For the study, the Particle Therapy market has been segmented as follows:

Best Medical International Signs a Memorandum of Understanding with University of Wisconsin Medical Radiation Research Center (UWMRRC) to Develop Revolutionary New Carbon Therapy

Thursday, January 30, 2020 - 11:00am

Best Medical International and Best Particle Therapy of TeamBest Companies, have recently entered into a Memorandum of Understanding (MOU) with the University of Wisconsin Medical Radiation Research Center (UWMRRC).

Key Points: 
  • Best Medical International and Best Particle Therapy of TeamBest Companies, have recently entered into a Memorandum of Understanding (MOU) with the University of Wisconsin Medical Radiation Research Center (UWMRRC).
  • Best Particle Therapy will be introducing their unique 400 MeV ion Rapid Cycling Medical Synchrotron (iRCMS) with Variable Energy, Heavy Ion Treatment Technologies, offering Proton-to-Carbon Heavy Ion, for Highly Precise, Conformal and Hypo-Fractionated Radiation Therapy.
  • The advantages of the Best 400 MeV iRCMS are:
    Small beam size small magnets, light gantries smaller footprint
    Flexibility heavy ion beam therapy (protons and/or carbon), beam delivery modalities.
  • University of Wisconsin and Best Medical are excited about the collaboration, as this brings much needed carbon ion therapy to Midwestern states such as Illinois, Wisconsin, Indiana, etc.

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

Wednesday, August 14, 2019 - 10:24am

STOCKHOLM, Aug. 14, 2019 /PRNewswire/ -- In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital.

Key Points: 
  • STOCKHOLM, Aug. 14, 2019 /PRNewswire/ -- In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital.
  • HIT has long expertise in advanced radiation therapy techniques and has been performing proton therapy and carbon ion therapy for the past 10 years.
  • Heidelberg University Hospital also treats patients using TomoTherapy, which is the focus of another cooperation between HIT and RaySearch.
  • Johan Lf, CEO of RaySearch, says: "We are proud to see Heidelberg's first carbon ion treatment using RayStation, and it is gratifying that all European centers have now chosen RayStation for carbon ion therapy.

United States $16 Billion Proton Therapy Markets to 2025

Tuesday, August 13, 2019 - 8:15pm

DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.
  • The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025.
  • In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase.
  • The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

United States Proton Therapy Markets 2009-2018 & 2019-2025: Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated - ResearchAndMarkets.com

Tuesday, August 13, 2019 - 1:07pm

The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.
  • The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025.
  • In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase.
  • The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Ten Years Ago Since First Order of RayStation Treatment Planning System

Wednesday, July 31, 2019 - 1:12pm

STOCKHOLM, July 31, 2019 /PRNewswire/ -- This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation.

Key Points: 
  • STOCKHOLM, July 31, 2019 /PRNewswire/ -- This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation.
  • After a few years in practice, RaySearch decided to develop its own treatment planning system, named RayStation.
  • Since this first order, RayStation has become the market leader in treatment planning for particle therapy globally.
  • As of today, RayStation is selected by 55 particle centers as their treatment planning system.